drugset / Trial / NCT01187225

Fibrinogen Concentrate In Children After Cardiac Surgery

NCT01187225

Phase 2 Completed 63 enrolled University of Sao Paulo CSL Behring · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate prospectively whether concentrate fibrinogen reduces blood losses, transfusion requirements and occurrence of clinical complications compared to cryoprecipitate in children after cardiac surgery with pump.

Timeline

Start
2010-08
Primary completion
2011-01
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cryoprecipitate Protein / enzyme biologic 10 unknown
Comparator Fibrinogen Concentrate Human Protein / enzyme biologic 60 mg/kg